FATE
Fate Therapeutics Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−7.35%
vs ±20.5% implied · ×0.36
shaded = implied · ▲▼ = realized
No thesis.
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Redmile GroupRedmile | $34.8M | 17.90% | 0.00% | |
| 2 | BlackRockBlackRockindex-like | $19.7M | 10.15% | −27.51% | |
| 3 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $12.3M | 6.32% | +9.95% | |
| 4 | Vanguard Capital ManagementVanguardindex-like | $12.0M | 6.18% | +6.05% | |
| 5 | Acadian Asset ManagementAcadian | $11.7M | 6.05% | +5.61% | |
| 6 | AQR Capital ManagementAQR | $10.4M | 5.34% | +27.84% | |
| 7 | Two Sigma InvestmentsTwo Sigma | $9.7M | 4.99% | +3.55% | |
| 8 | Johnson & JohnsonJohnson & Johnson | $9.1M | 4.70% | 0.00% | |
| 9 | Renaissance TechnologiesRenaissance Technologies | $8.1M | 4.15% | +0.29% | |
| 10 | Millennium ManagementMillennium | $6.6M | 3.39% | new | |
| 11 | Goldman Sachs GroupGoldman Sachs | $5.5M | 2.85% | +54.33% | |
| 12 | Geode Capital ManagementGeodeindex-like | $3.6M | 1.84% | −48.97% | |
| 13 | Jane Street GroupJane Street | $3.0M | 1.56% | +69.50% | |
| 14 | Citadel AdvisorsCitadel | $3.0M | 1.52% | +12.72% | |
| 15 | T. Rowe Price Investment ManagementT. Rowe Price | $2.9M | 1.50% | new | |
| 16 | BruceBruce | $2.7M | 1.38% | +25.34% | |
| 17 | Morgan StanleyMorgan Stanley | $1.9M | 0.97% | −9.53% | |
| 18 | Susquehanna International GroupSusquehanna International | $1.8M | 0.93% | +76.62% | |
| 19 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $1.7M | 0.89% | −2.04% | |
| 20 | Charles Schwab Investment ManagementCharles Schwabindex-like | $1.6M | 0.85% | −19.22% | |
| 21 | UBS GroupUBS | $1.6M | 0.82% | −67.60% | |
| 22 | Qube Research & TechnologiesQube Research & Technologies | $1.6M | 0.80% | new | |
| 23 | Connor, Clark & Lunn Investment ManagementConnor, Clark & Lunn | $1.6M | 0.80% | +22.40% | |
| 24 | State StreetState Streetindex-like | $1.5M | 0.78% | −75.30% | |
| 25 | DAFNA Capital ManagementDAFNA | $1.4M | 0.73% | −4.55% |
155 managers report $194.1M of Fate Therapeutics on form 13F for the quarter ended Jun 30 '26. 17 of them hold 80% of it; Redmile is largest at 17.90%.
Fate Therapeutics Inc
2.08
−0.09 · −4.16%
post 2.08 0.00%
No implied move.
No implied move.
Expected move
No implied move.